PCSK9 and familial hyperaldosteronism: The combination of an LDLR mutation with a p.(V4I) PCSK9 mutation in clinically diagnosed FH yields a severe phenotype and makes the patient to be more prone to CAD (Ohta et al., 2016; Shirahama et al., 2018).